A guide for adults with AML and the people supporting them.
Sources checked September 27, 2026. Educational only. Individual clinician review of this guide is not yet documented. Your leukemia team must personalize testing and treatment.
AML is a cancer of blood-forming cells in the bone marrow. Abnormal immature cells can interfere with production of healthy blood cells. Untreated AML can progress quickly and needs prompt specialist evaluation.
Symptoms may include fatigue, weakness, pale skin, fever, infections, and unusual bruising or bleeding. These symptoms also occur in other illnesses. Symptoms alone cannot diagnose leukemia.
A complete blood count measures blood cell levels. A blood smear examines their appearance. Bone marrow sampling and flow cytometry help identify the abnormal cells. Chromosome and molecular tests clarify the subtype and help guide treatment.
Ask for a copy of the marrow report and genetic results. Acute promyelocytic leukemia, or APL, is a distinct AML subtype associated with dangerous bleeding and clotting. Suspected APL needs immediate specialist attention and a different treatment approach.
There is no single treatment plan for everyone. Leukemia genetics, overall health, organ function, previous treatment, and personal goals shape the recommendation.
Some people receive intensive chemotherapy. Others receive less-intensive combinations, such as a hypomethylating medicine with venetoclax. Targeted drugs may be appropriate for certain mutations. Less-intensive treatment can still cause serious low blood counts and infections and requires close monitoring.
Remission is an important response, but does not automatically mean cure. Additional treatment may include consolidation chemotherapy or a donor stem cell transplant in selected patients. Transplant decisions balance relapse risk against treatment risks.
Repeat blood and marrow tests assess response. Measurable residual disease, or MRD, testing looks for small amounts of leukemia using sensitive methods. If AML persists or returns, repeat testing can help guide further therapy. Clinical trials may be worth discussing at diagnosis as well as later.
During cancer treatment, fever or other infection symptoms can require urgent care, especially when neutrophils are low. Contact your oncology team immediately for a temperature of 100.4°F (38°C) or higher, or at the lower threshold they gave you. Do not wait until the next appointment. Ask before taking fever-reducing medicines because they can mask infection.
Also report chills, a new cough, painful urination, or redness around a catheter. Keep your team’s daytime and after-hours numbers available.
Call 911 or your local emergency number for severe trouble breathing, uncontrolled bleeding, loss of consciousness, or another life-threatening emergency.
Bring your medication list and a support person if you wish. Ask the team to write down the plan and the next decision point.